Cincinnati, OH - 30 April 2014 - Medpace Reference Laboratories LLC (MRL), a Medpace company, has opened a newly built, state-of-the-art central laboratory in Singapore. Medpace Laboratories, Singapore will serve and support new and existing Medpace pharmaceutical clients conducting clinical research in the rapidly expanding Asia Pacific region. With dedicated project management and logistic teams, the central lab is fully integrated into ClinTrak(R) -- Medpace's proprietary global decision support technology, allowing the transfer of real time data to support clinical studies.
The Singapore facilities have been equipped with identical instrumentation, and use the same reagent systems, calibration, QA process and SOPs. Medpace Laboratories, Singapore will provide routine safety, biomarker and reference methodologies identical to Medpace Reference Laboratories in Cincinnati, USA; Leuven, Belgium; and Beijing, China.
Medpace is a global full-service clinical research organization (CRO) providing Phase I-IV core development services for drug, biologic, and device programs. Medpace employs over 1700 employees and has clinical trial experience in over 45 countries and 6 regions -- the US, Europe, Central and Eastern Europe, India, Asia Pacific, and China.